MedPath

Prevalence of gastroesophageal reflux evaluated by upper gastrointestinal tract examination in ataff health check, and its associations with metabolic syndrome.

Not Applicable
Conditions
Gastroesophageal reflux disease
Registration Number
JPRN-UMIN000000616
Lead Sponsor
Division of Gastroenterology, Department of Internal Medicine, Keio University School of Medicine
Brief Summary

Two hundred and eighty-three subjects (243 men and 40 women; mean age 49.8 +/- 6.9 years) with no radiographic evidence of erosive esophagitis were enrolled. The severity of GER was worse among men than among women, whereas the severity of reflux symptoms was worse among women. The severity of GER was associated with age and serum triglyceride levels in men, and with the serum low-density lipoprotein cholesterol levels in women. The severity of reflux symptoms, however, was not associated with metabolic parameters. There were more women than men with reflux symptoms but without GER ('presumed' functional heartburn group), compared with subjects with neither GER nor reflux symptoms. In men, the presence of both reflux symptoms and GER ('presumed' NERD group) was associated with the serum triglyceride levels. CONCLUSIONS & INFERENCES: While NERD is associated with serum lipid levels, functional heartburn is not. The prevalence of GER was greater among men; conversely, the prevalence of functional heartburn was greater among women.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

Indivisuals who have any disease such as aliment disease or medical treatment were excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
(1) Prevalence of gastroesophageal reflux disease in stuff members undergoing upper gastro intestinal X-ray examination in health check. (2) Relationship between severity of gastroesophageal reflux and metabolic marker.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath